Greta E. Noland builds and manages global patent portfolios for clients in the biotechnology and pharmaceutical industries.  As a component of her portfolio management, Ms. Noland represents clients in interference and appeal proceedings in the United States, and guides clients through opposition, appeal, conflict and revocation proceedings in other countries.  She also frequently performs due diligence analyses for intellectual property transactions and public stock offerings.  By virtue of working for academic, not-for-profit, private and public entities, her advice encompasses many perspectives important for product life cycle management.  Ms. Noland achieves clients’ goals by delivering creative, attentive service molded by over twenty years of experience in the field.

Recent Client Work

  • Prosecuting a U.S. accelerated examination application claiming methods of predicting development of a diabetic condition.
  • Defending an opposition against a European patent protecting the method of manufacture for a blockbuster cytokine product.
  • Completing due diligence analyses for a client’s acquisition of a FDA-approved bone graft product.

Detailed Biography

Representative Experience

Ms. Noland has advanced clients’ rights in such technologies as:

  • Novel gene products including cellular adhesion molecules, chemokines, hormones, G proteins, phosphodiesterases, phosphatases and kinases
  • Therapeutic and diagnostic antibody products
  • Viral vectors and vaccines
  • Genetic engineering of plants
  • Gene regulation techniques
  • Diagnostic and prognostic methods 

Background and Credentials

Ms. Noland was registered as a patent agent in 1991. Previously, she earned a B.S. in Microbiology from the University of Notre Dame and an M.S. in Molecular Biology from Northwestern University.

Representative Matters

Adams (Monsanto)* v. Leemans (Bayer Crop Sciences)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Barton v. Fischhoff* (Monsanto) v. Adang (Mycogen Plant Science)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Birkenbach v. Godiska (ICOS Corporation)*
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Conflict re: Kirin-Amgen, Inc.*
Canadian Intellectual Property Office
Case Type(s): Conflict
Area(s) of practice: Pharmaceuticals

Conflict re: Monsanto Company*
Canadian Intellectual Property Office
Case Type(s): Conflict
Area(s) of practice: Biotechnology

Fraley (Monsanto)* v. Zambryski v. Anderson
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Fraley (Monsanto)* v. Comai
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Fraley (Monsanto)* v. Zambryski
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Godiska (ICOS Corporation)* v. Li (Human Genome Sciences)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Pharmaceuticals

Invalidity Action re: Pfizer Research and Development Company
Canadian Federal Court
Area(s) of practice: Pharmaceuticals

Masinovsky (ICOS Corporation)* v. Newman v. Rice
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Opposition and Appeal re: Kirin-Amgen, Inc.*
European Patent Office
Case Type(s): Opposition, Appeal
Area(s) of practice: Pharmaceuticals

Opposition and Appeal re: Pfizer Limited
European Patent Office
Case Type(s): Opposition, Appeal
Area(s) of practice: Pharmaceuticals

Opposition and Appeal re: Protein Design Labs, Inc.
European Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Opposition and Federal Court Appeal re: Kirin-Amgen, Inc.*
Australian Patent Office and Federal Court
Case Type(s): Opposition, Appeal
Area(s) of practice: Pharmaceuticals

Opposition and Appeal re: Amgen, Inc.*
European Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Opposition Division of the European Patent Office
Case Type(s): Opposition
Area(s) of practice: Biotechnology

Opposition re: Genentech, Inc.
European Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Opposition re: Genetics Institute, Inc.
Australian Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals, Biotechnology

Opposition re: Kirin-Amgen, Inc.*
Israeli Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Revocation and Amendment Proceedings re: Kirin-Amgen, Inc.*
The Court of the Commissioner of Patents for The Republic of South Africa
Area(s) of practice: Pharmaceuticals

Revocation and Appeal re: Pfizer Limited
UK High Court of Justice and Supreme Court of Judicature Court of Appeal
Case Type(s): Appeal
Area(s) of practice: Pharmaceuticals

Schilperoort v. Rogers (Monsanto)* v. Barton v. Zambryski
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology 

Vanderbilt v. ICOS Corporation*
U.S. District Court
Case Type(s): Patent Litigation
Area(s) of practice: Pharmaceuticals

*Party Represented

Short Biography

Education

  • Northwestern University, M.S., Molecular Biology
  • University of Notre Dame, B.S., Microbiology

Practices

Industries

Admissions

  • U.S. Patent and Trademark Office

Greta E. Noland

Patent Agent

Greta E. Noland builds and manages global patent portfolios for clients in the biotechnology and pharmaceutical industries.  As a component of her portfolio management, Ms. Noland represents clients in interference and appeal proceedings in the United States, and guides clients through opposition, appeal, conflict and revocation proceedings in other countries.  She also frequently performs due diligence analyses for intellectual property transactions and public stock offerings.  By virtue of working for academic, not-for-profit, private and public entities, her advice encompasses many perspectives important for product life cycle management.  Ms. Noland achieves clients’ goals by delivering creative, attentive service molded by over twenty years of experience in the field.

  • T.312.423.3449
  • F.312.474.0448

Greta E. Noland

Greta E. Noland

Recent Client Work

  • Prosecuting a U.S. accelerated examination application claiming methods of predicting development of a diabetic condition.
  • Defending an opposition against a European patent protecting the method of manufacture for a blockbuster cytokine product.
  • Completing due diligence analyses for a client’s acquisition of a FDA-approved bone graft product.

Detailed Biography

Representative Experience

Ms. Noland has advanced clients’ rights in such technologies as:

  • Novel gene products including cellular adhesion molecules, chemokines, hormones, G proteins, phosphodiesterases, phosphatases and kinases
  • Therapeutic and diagnostic antibody products
  • Viral vectors and vaccines
  • Genetic engineering of plants
  • Gene regulation techniques
  • Diagnostic and prognostic methods 

Background and Credentials

Ms. Noland was registered as a patent agent in 1991. Previously, she earned a B.S. in Microbiology from the University of Notre Dame and an M.S. in Molecular Biology from Northwestern University.

Representative Matters

Adams (Monsanto)* v. Leemans (Bayer Crop Sciences)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Barton v. Fischhoff* (Monsanto) v. Adang (Mycogen Plant Science)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Birkenbach v. Godiska (ICOS Corporation)*
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Conflict re: Kirin-Amgen, Inc.*
Canadian Intellectual Property Office
Case Type(s): Conflict
Area(s) of practice: Pharmaceuticals

Conflict re: Monsanto Company*
Canadian Intellectual Property Office
Case Type(s): Conflict
Area(s) of practice: Biotechnology

Fraley (Monsanto)* v. Zambryski v. Anderson
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Fraley (Monsanto)* v. Comai
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Fraley (Monsanto)* v. Zambryski
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Godiska (ICOS Corporation)* v. Li (Human Genome Sciences)
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Pharmaceuticals

Invalidity Action re: Pfizer Research and Development Company
Canadian Federal Court
Area(s) of practice: Pharmaceuticals

Masinovsky (ICOS Corporation)* v. Newman v. Rice
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Opposition and Appeal re: Kirin-Amgen, Inc.*
European Patent Office
Case Type(s): Opposition, Appeal
Area(s) of practice: Pharmaceuticals

Opposition and Appeal re: Pfizer Limited
European Patent Office
Case Type(s): Opposition, Appeal
Area(s) of practice: Pharmaceuticals

Opposition and Appeal re: Protein Design Labs, Inc.
European Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Opposition and Federal Court Appeal re: Kirin-Amgen, Inc.*
Australian Patent Office and Federal Court
Case Type(s): Opposition, Appeal
Area(s) of practice: Pharmaceuticals

Opposition and Appeal re: Amgen, Inc.*
European Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Opposition Division of the European Patent Office
Case Type(s): Opposition
Area(s) of practice: Biotechnology

Opposition re: Genentech, Inc.
European Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Opposition re: Genetics Institute, Inc.
Australian Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals, Biotechnology

Opposition re: Kirin-Amgen, Inc.*
Israeli Patent Office
Case Type(s): Opposition
Area(s) of practice: Pharmaceuticals

Revocation and Amendment Proceedings re: Kirin-Amgen, Inc.*
The Court of the Commissioner of Patents for The Republic of South Africa
Area(s) of practice: Pharmaceuticals

Revocation and Appeal re: Pfizer Limited
UK High Court of Justice and Supreme Court of Judicature Court of Appeal
Case Type(s): Appeal
Area(s) of practice: Pharmaceuticals

Schilperoort v. Rogers (Monsanto)* v. Barton v. Zambryski
U.S. Patent Office
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology 

Vanderbilt v. ICOS Corporation*
U.S. District Court
Case Type(s): Patent Litigation
Area(s) of practice: Pharmaceuticals

*Party Represented

Short Biography

Greta E. Noland

Education

  • Northwestern University, M.S., Molecular Biology
  • University of Notre Dame, B.S., Microbiology

Practices

Industries

Admissions

  • U.S. Patent and Trademark Office
©2012 Marshall, Gerstein & Borun LLP